Newark, New Castle, USA, May 26, 2023 (GLOBE NEWSWIRE) — Growth Plus Reports estimated the size of the global market for cutting angioplasty balloons in 2022 to be worth US$ 218.38 million, and it is expected to increase at a revenue CAGR of 6.32% to reach US$ 356.56 million by 2031.
The global market for cutting angioplasty balloons was analyzed and is expected to significantly increase revenue share during the forecast period. A medical instrument called a cutting angioplasty balloon is employed in interventional cardiology to treat blood vessels that are blocked or constrained, notably those in the coronary arteries.
Key Takeaways:
- The increasing number of patients with cardiovascular diseases is driving the market revenue share.
- Technological advancements in surgical procedures are driving the market demand.
- The rising demand for minimally invasive procedures is raising the market revenue growth rapidly.
Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/cutting-angioplasty-balloon-market/8822
Cutting Angioplasty Balloon Market Scope
Report Attribute | Details |
Market Size Value in 2022 | US$ 218.38 million |
Revenue Forecast in 2031 | US$ 356.56 million |
CAGR | 6.32% |
Base Year for Estimation | 2022 |
Forecast Period | 2023 to 2031 |
Historical Year | 2021 |
Segments Covered | Product Type, Application, End User, and Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Recent Development in the Cutting Angioplasty Balloon Market:
- In September 2022, Lepu Medical Technology (Beijing) Co., Ltd. was given marketing approval for its Vesscide peripheral cutting balloon by China’s National Medical Products Administration, which is used to treat peripheral artery disease.
- In July 2022, The Food and Drug Administration granted BrosMed Medical approval for its TicheTM 0.035″ PTA Balloon Dilatation Catheter.
Competitive Landscape
A list of the prominent players operating in the global market for cutting angioplasty balloons includes:
- Abbott Laboratories, Inc.
- Becton Dickinson & Company
- Cook Medical
- Koninklijke Philips N.V.
- Merit Medical Systems, Inc.
Market Drivers and Restraints:
The global cutting angioplasty balloon market revenue is driven by rising cardiovascular disease, growing awareness and preference for minimally invasive procedures, and increasing healthcare expenditure. Furthermore, favorable government initiatives and reimbursement policies are contributing to the market revenue share.
However, due to the high prices, the scarcity of specialists with the necessary skills, and the limited availability of cutting-edge medical facilities, the cutting angioplasty balloon market revenue growth is expected to be restrained.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/cutting-angioplasty-balloon-market/8822
Market Segmentation:
Segmentation By Type
Based on the types, the conventional cutting balloons segment dominates the global cutting angioplasty balloon market with the largest revenue share. This large revenue share is attributed to their effectiveness in successfully increasing blood flow and minimizing the need for additional procedures.
Segmentation By Application
Based on the application, the coronary artery diseases segment dominates the global cutting angioplasty balloon market with the largest revenue share. The significant revenue share is attributed to the rising prevalence of coronary artery diseases and successful patient outcomes. Furthermore, the growing adoption of minimally invasive procedures is contributing to the market revenue growth.
Segmentation By End User
Based on end-user, the hospital’s segment accounts for the highest revenue share in the global cutting angioplasty balloon market due to the cutting-edge medical facilities, prevalence of chronic disease, and adoption of telemedicine by hospitals.
Regional Growth Dynamics
Based on the region, North America, with the largest revenue share, dominates the global cutting angioplasty balloon market. The demand for cutting angioplasty balloons is driven by the rising frequency of cardiovascular diseases and the expanding use of minimally invasive techniques in this region. The expansion of the cutting angioplasty balloon market in North America is also being aided by the presence of significant market players and reimbursement policies in the region.
Report Coverage
Growth Plus Reports analyzed the global market for cutting angioplasty balloons in-depth. We studied the fundamental market characteristics, significant investment sectors, regional growth analytics, revenue estimates, competing market players, and mergers and acquisitions.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL CUTTING ANGIOPLASTY BALLOONS MARKET – ANALYSIS & FORECAST, BY PRODUCT TYPE
- Conventional Cutting Balloons
- Drug Coated Cutting Balloons
- Scoring Balloons
- GLOBAL CUTTING ANGIOPLASTY BALLOONS MARKET – ANALYSIS & FORECAST, BY APPLICATION
- Peripheral Artery Diseases
- Coronary Artery Diseases
- GLOBAL CUTTING ANGIOPLASTY BALLOONS MARKET – ANALYSIS & FORECAST, BY END USER
- Cardiac Centers
- Hospitals
- Others
CUTTING ANGIOPLASTY BALLOONS MARKET TOC
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8822
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse more latest healthcare reports:
Retrovirus Testing Market by Test Type (Antibody Test, Antigen/Antibody Test), Technique Type (ELISA, PCR), Sample Type (Serum, Blood) – Global Outlook & Forecast 2023-2031
Southern Blotting Market by Products (Consumables and Instruments), Application (Medical Diagnosis, Genetic Fingerprinting, Scientific Research), End User (Biotechnology & Pharmaceutical Industries, Research Institutes) – Global Outlook and Forecast 2023-2031
Laser Indirect Opthalmoscope Market by Laser Type (Photocoagulating Laser Indirect Ophthalmoscope, Photo Disrupting Laser Indirect Ophthalmoscope), Therapeutic Application (Diabetic Retinopathy, Lattice Degeneration), End User (Ophthalmic Clinics, Multispecialty Hospitals) – Global Outlook & Forecast 2023-2031
AI in Endoscopy Market by Application (Bronchoscopy, Gastrointestinal Endoscopy), Component (Hardware, Software), End User (Hospitals, Ambulatory Care Centers) – Global Outlook & Forecast 2023-2031
Recording Chart Papers Market by Type (Ultrasound / OBGYN Recording Chart Papers, Fetal Monitoring Recording Chart Papers), End User (Hospitals & Clinics, Diagnostic Centers) – Global Outlook & Forecast 2023-2031
Unleashing the Power of Innovation in Med Tech https://growthplusmedtechroundup.com/
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.